Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Crinetics Pharmaceuticals, Inc. | Chief Medical Officer | Common Stock | 43.2K | $1.63M | $37.65 | Oct 17, 2023 | Direct |
Crinetics Pharmaceuticals, Inc. | Chief Medical Officer | Non-qualified stock option (Right to Buy) | 153K | Oct 17, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRNX | Crinetics Pharmaceuticals, Inc. | Oct 17, 2023 | 3 | -$126K | 4 | Oct 19, 2023 | Chief Medical Officer |
CRNX | Crinetics Pharmaceuticals, Inc. | Mar 16, 2023 | 1 | -$28.9K | 4 | Mar 17, 2023 | Chief Medical Officer |
CRNX | Crinetics Pharmaceuticals, Inc. | Mar 1, 2023 | 2 | $0 | 4 | Mar 3, 2023 | Chief Medical Officer |
CRNX | Crinetics Pharmaceuticals, Inc. | Dec 31, 2022 | 2 | $21.2K | 5 | Jan 27, 2023 | Chief Medical Officer |
CRNX | Crinetics Pharmaceuticals, Inc. | Feb 28, 2022 | 2 | $0 | 4 | Mar 2, 2022 | Chief Medical Officer |
CRNX | Crinetics Pharmaceuticals, Inc. | Jan 19, 2022 | 3 | -$61.6K | 4 | Jan 21, 2022 | Chief Medical Officer |